Market Outlook
The global Pertussis Vaccine market size was valued at USD 5338.1 million in 2022 and is forecast to a readjusted size of USD 6722.7 million by 2029 with a CAGR of 3.3% during review period.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.
This report is a detailed and comprehensive analysis for global Pertussis Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pertussis Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2018-2029
Global Pertussis Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2018-2029
Global Pertussis Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2018-2029
Global Pertussis Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/Doses), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pertussis Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pertussis Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
KM Biologics
Chengdu Institute of Biological Products
Segmentation By Type
Whole-cell Vaccines
Acellular Vaccines
Segmentation By Application
12 Months Below
12 Months Above
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the pertussis vaccine market in 2025?
The pertussis vaccine market benefits from a strong awareness of vaccine-preventable diseases and increased public health initiatives promoting vaccination. This awareness leads to higher vaccination rates, reducing the incidence of pertussis. Additionally, technological advancements in vaccine development contribute to improved efficacy and safety profiles.
What are the weaknesses of the pertussis vaccine market in 2025?
One significant weakness is vaccine hesitancy, fueled by misinformation about vaccine safety and efficacy. This hesitancy can hinder vaccination coverage, leaving populations vulnerable to outbreaks. Furthermore, reliance on outdated vaccination schedules may limit uptake in certain demographics.
What are the opportunities in the pertussis vaccine market in 2025?
The market presents opportunities for innovative vaccine formulations and combination vaccines that address multiple diseases. Collaborations between pharmaceutical companies and public health organizations can enhance outreach and education efforts, further improving vaccination rates. Additionally, emerging markets show potential for growth as healthcare infrastructures improve.
What are the threats to the pertussis vaccine market in 2025?
Threats include the potential for new pertussis strains to emerge, which could impact vaccine effectiveness. Regulatory changes and funding cuts for vaccination programs may also pose challenges. Furthermore, competition from alternative immunization methods or therapies could threaten market share for traditional vaccines.
Market PESTEL Analysis
What are the political factors affecting the pertussis vaccine market in 2025?
Government vaccination mandates and immunization programs play a crucial role in market growth. Policies supporting routine childhood vaccinations drive demand, but geopolitical instability and regulatory changes can disrupt vaccine distribution and funding.
What are the economic factors influencing the pertussis vaccine market in 2025?
Economic growth in emerging markets creates opportunities for expanded vaccine access. However, budget constraints in healthcare systems and fluctuating production costs may impact affordability and distribution, particularly in low-income regions.
What are the social factors impacting the pertussis vaccine market in 2025?
Public perception of vaccines, driven by awareness campaigns and misinformation, significantly affects vaccination rates. An aging population and increasing global travel also raise the need for booster vaccinations to prevent outbreaks.
What are the technological factors shaping the pertussis vaccine market in 2025?
Advancements in vaccine technology, including improved formulations and adjuvants, enhance efficacy and reduce side effects. Digital health initiatives, such as electronic vaccination records and AI-driven epidemiology, improve monitoring and distribution strategies.
What are the environmental factors affecting the pertussis vaccine market in 2025?
Cold chain logistics remain a challenge, especially in remote areas, where temperature-sensitive vaccines may face storage and transport issues. Climate change-related disruptions, such as natural disasters, can further hinder vaccine distribution.
What are the legal factors influencing the pertussis vaccine market in 2025?
Stringent regulatory requirements for vaccine approval ensure safety but may slow down innovation and market entry. Legal actions related to vaccine side effects, as well as intellectual property rights, can also impact manufacturers and market dynamics.
Market SIPOC Analysis
Who are the key suppliers in the pertussis vaccine market in 2025?
Suppliers include pharmaceutical companies manufacturing vaccines, raw material providers for antigens and adjuvants, and research institutions developing new formulations. Cold chain logistics providers also play a crucial role in maintaining vaccine integrity.
What are the main inputs in the pertussis vaccine market in 2025?
Key inputs consist of vaccine antigens, stabilizers, preservatives, vials, syringes, and cold storage facilities. Regulatory approvals and funding for vaccine production and distribution are also essential components.
What are the core processes involved in the pertussis vaccine market in 2025?
The process includes research and development, clinical trials, regulatory approval, large-scale production, quality control, distribution, and vaccination administration. Post-market surveillance ensures vaccine safety and effectiveness.
Who are the primary outputs in the pertussis vaccine market in 2025?
Outputs include different formulations of pertussis vaccines, such as standalone and combination vaccines. Other key outputs include immunization programs, public health reports, and epidemiological data on vaccine effectiveness.
Who are the main customers in the pertussis vaccine market in 2025?
Customers include government healthcare agencies, hospitals, private clinics, pharmacies, and international organizations like WHO and UNICEF. End users are infants, children, healthcare workers, and adults requiring booster doses.
Market Porter's Five Forces
How intense is the competition among existing players in the pertussis vaccine market in 2025?
The market is highly competitive, with established pharmaceutical companies dominating production. Continuous R&D, regulatory compliance, and large-scale manufacturing capabilities create barriers to entry, but pricing pressures and innovation drive competition.
What is the threat of new entrants in the pertussis vaccine market in 2025?
The threat is low due to strict regulatory approvals, high R&D costs, and the need for extensive distribution networks. However, advancements in biotechnology and government funding for new vaccine developers could encourage some new players.
How strong is the bargaining power of suppliers in the pertussis vaccine market in 2025?
Suppliers of raw materials, including antigens, stabilizers, and cold chain logistics, hold moderate power. Limited sources for high-quality biological ingredients can drive up costs, but established manufacturers mitigate risks through diversified supply chains.
How strong is the bargaining power of buyers in the pertussis vaccine market in 2025?
Buyers, including governments, healthcare providers, and international organizations, have significant bargaining power. Bulk purchasing, negotiated contracts, and pricing regulations allow them to influence vaccine pricing and availability.
What is the threat of substitutes in the pertussis vaccine market in 2025?
The threat is low, as vaccination remains the most effective preventive measure against pertussis. However, advancements in alternative immunization methods, such as monoclonal antibodies or novel therapeutics, could pose a potential challenge in the long term.
Market Upstream Analysis
What are the key raw materials required in the pertussis vaccine market in 2025?
Essential raw materials include Bordetella pertussis antigens, adjuvants to enhance immune response, preservatives for stability, and sterile vials or syringes. Cold chain infrastructure is also crucial for maintaining vaccine efficacy.
Who are the main suppliers in the upstream pertussis vaccine market in 2025?
Suppliers include biotechnology firms producing bacterial strains, chemical manufacturers providing stabilizers and preservatives, and packaging companies supplying vials and syringes. Logistics providers ensure proper cold storage and transportation.
What challenges do suppliers face in the pertussis vaccine market in 2025?
Challenges include maintaining high-quality standards, meeting stringent regulatory requirements, and ensuring a stable supply of raw materials. Disruptions in global supply chains, geopolitical instability, and fluctuating costs can also impact production.
How does upstream supply impact vaccine pricing in the pertussis vaccine market in 2025?
Limited availability of key raw materials and specialized manufacturing processes contribute to high production costs. Any disruptions in the upstream supply chain, such as shortages or regulatory delays, can drive up vaccine prices and affect market accessibility.
What strategies can manufacturers adopt to strengthen upstream supply chains in 2025?
Manufacturers can establish long-term contracts with multiple suppliers, invest in local production facilities, and enhance cold chain logistics. Collaborations with biotech firms and governments can also help secure a stable supply of critical raw materials.
Market Midstream Analysis
Who are the key players involved in the midstream pertussis vaccine market in 2025?
Midstream players include pharmaceutical companies responsible for vaccine formulation, large-scale manufacturing, and quality control. Contract manufacturing organizations (CMOs) also play a role in meeting global demand.
What are the critical processes in the midstream pertussis vaccine market in 2025?
Key processes include antigen production, vaccine formulation, purification, quality testing, regulatory compliance, and large-scale manufacturing. Strict adherence to Good Manufacturing Practices (GMP) ensures product safety and efficacy.
What challenges does the midstream pertussis vaccine market face in 2025?
Challenges include maintaining production efficiency, meeting evolving regulatory requirements, and addressing quality control issues. Manufacturing disruptions due to supply chain constraints or facility upgrades can also impact vaccine availability.
How does midstream production influence vaccine distribution in 2025?
Efficient midstream production ensures a steady vaccine supply to distributors and healthcare providers. Any delays in manufacturing or regulatory approvals can create bottlenecks, affecting global immunization efforts.
What strategies can improve midstream operations in the pertussis vaccine market in 2025?
Investing in advanced manufacturing technologies, expanding production capacity, and enhancing regulatory compliance can improve efficiency. Partnerships with government agencies and global health organizations also help streamline vaccine production and distribution.
Market Downstream Analysis
Who are the key stakeholders in the downstream pertussis vaccine market in 2025?
Key stakeholders include healthcare providers, hospitals, clinics, pharmacies, government immunization programs, and international organizations like WHO and UNICEF. Patients and caregivers are the ultimate end-users.
What are the main distribution channels for pertussis vaccines in 2025?
Vaccines are distributed through public health initiatives, private healthcare providers, pharmacies, and vaccination drives in schools and workplaces. Digital health platforms also facilitate vaccine awareness and appointment scheduling.
What challenges exist in the downstream pertussis vaccine market in 2025?
Challenges include vaccine hesitancy, logistical hurdles in last-mile delivery, and disparities in vaccine access between urban and rural areas. Misinformation and policy changes can also affect public uptake.
How does downstream efficiency impact vaccination coverage in 2025?
Efficient downstream distribution ensures timely and widespread vaccine availability, reducing the risk of outbreaks. Any delays in delivery, storage issues, or public distrust can lower immunization rates and compromise herd immunity.
What strategies can improve downstream vaccine access in 2025?
Expanding mobile vaccination units, enhancing cold chain logistics, and strengthening public health campaigns can improve access. Partnerships between governments, NGOs, and private healthcare providers can also enhance vaccination outreach and education.
Chapter 1, to describe Pertussis Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pertussis Vaccine, with price, sales, revenue and global market share of Pertussis Vaccine from 2018 to 2023.
Chapter 3, the Pertussis Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pertussis Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pertussis Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pertussis Vaccine.
Chapter 14 and 15, to describe Pertussis Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Pertussis Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pertussis Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Whole-cell Vaccines
1.3.3 Acellular Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Pertussis Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 12 Months Below
1.4.3 12 Months Above
1.5 Global Pertussis Vaccine Market Size & Forecast
1.5.1 Global Pertussis Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pertussis Vaccine Sales Quantity (2018-2029)
1.5.3 Global Pertussis Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Pertussis Vaccine Product and Services
2.1.4 Sanofi Pasteur Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Pasteur Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Pertussis Vaccine Product and Services
2.2.4 GSK Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments/Updates
2.3 Mitsubishi Tanabe Pharma
2.3.1 Mitsubishi Tanabe Pharma Details
2.3.2 Mitsubishi Tanabe Pharma Major Business
2.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Product and Services
2.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
2.4 Wuhan Institute of Biological Products
2.4.1 Wuhan Institute of Biological Products Details
2.4.2 Wuhan Institute of Biological Products Major Business
2.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Product and Services
2.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Wuhan Institute of Biological Products Recent Developments/Updates
2.5 Walvax Biotechnology
2.5.1 Walvax Biotechnology Details
2.5.2 Walvax Biotechnology Major Business
2.5.3 Walvax Biotechnology Pertussis Vaccine Product and Services
2.5.4 Walvax Biotechnology Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Walvax Biotechnology Recent Developments/Updates
2.6 Minhai Biotechnology
2.6.1 Minhai Biotechnology Details
2.6.2 Minhai Biotechnology Major Business
2.6.3 Minhai Biotechnology Pertussis Vaccine Product and Services
2.6.4 Minhai Biotechnology Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Minhai Biotechnology Recent Developments/Updates
2.7 KM Biologics
2.7.1 KM Biologics Details
2.7.2 KM Biologics Major Business
2.7.3 KM Biologics Pertussis Vaccine Product and Services
2.7.4 KM Biologics Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 KM Biologics Recent Developments/Updates
2.8 Chengdu Institute of Biological Products
2.8.1 Chengdu Institute of Biological Products Details
2.8.2 Chengdu Institute of Biological Products Major Business
2.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Product and Services
2.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Chengdu Institute of Biological Products Recent Developments/Updates
3 Competitive Environment: Pertussis Vaccine by Manufacturer
3.1 Global Pertussis Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pertussis Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Pertussis Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pertussis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pertussis Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Pertussis Vaccine Manufacturer Market Share in 2022
3.5 Pertussis Vaccine Market: Overall Company Footprint Analysis
3.5.1 Pertussis Vaccine Market: Region Footprint
3.5.2 Pertussis Vaccine Market: Company Product Type Footprint
3.5.3 Pertussis Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pertussis Vaccine Market Size by Region
4.1.1 Global Pertussis Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Pertussis Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Pertussis Vaccine Average Price by Region (2018-2029)
4.2 North America Pertussis Vaccine Consumption Value (2018-2029)
4.3 Europe Pertussis Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Pertussis Vaccine Consumption Value (2018-2029)
4.5 South America Pertussis Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Pertussis Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Pertussis Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Pertussis Vaccine Consumption Value by Type (2018-2029)
5.3 Global Pertussis Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Pertussis Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Pertussis Vaccine Consumption Value by Application (2018-2029)
6.3 Global Pertussis Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Pertussis Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Pertussis Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Pertussis Vaccine Market Size by Country
7.3.1 North America Pertussis Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Pertussis Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Pertussis Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Pertussis Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Pertussis Vaccine Market Size by Country
8.3.1 Europe Pertussis Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Pertussis Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Pertussis Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pertussis Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pertussis Vaccine Market Size by Region
9.3.1 Asia-Pacific Pertussis Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pertussis Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Pertussis Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Pertussis Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Pertussis Vaccine Market Size by Country
10.3.1 South America Pertussis Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Pertussis Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Pertussis Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pertussis Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pertussis Vaccine Market Size by Country
11.3.1 Middle East & Africa Pertussis Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pertussis Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Pertussis Vaccine Market Drivers
12.2 Pertussis Vaccine Market Restraints
12.3 Pertussis Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Pertussis Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pertussis Vaccine
13.3 Pertussis Vaccine Production Process
13.4 Pertussis Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pertussis Vaccine Typical Distributors
14.3 Pertussis Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Pertussis Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pertussis Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Pertussis Vaccine Product and Services
Table 6. Sanofi Pasteur Pertussis Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Pasteur Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Pertussis Vaccine Product and Services
Table 11. GSK Pertussis Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GSK Recent Developments/Updates
Table 13. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Mitsubishi Tanabe Pharma Major Business
Table 15. Mitsubishi Tanabe Pharma Pertussis Vaccine Product and Services
Table 16. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 18. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 19. Wuhan Institute of Biological Products Major Business
Table 20. Wuhan Institute of Biological Products Pertussis Vaccine Product and Services
Table 21. Wuhan Institute of Biological Products Pertussis Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Wuhan Institute of Biological Products Recent Developments/Updates
Table 23. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 24. Walvax Biotechnology Major Business
Table 25. Walvax Biotechnology Pertussis Vaccine Product and Services
Table 26. Walvax Biotechnology Pertussis Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Walvax Biotechnology Recent Developments/Updates
Table 28. Minhai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 29. Minhai Biotechnology Major Business
Table 30. Minhai Biotechnology Pertussis Vaccine Product and Services
Table 31. Minhai Biotechnology Pertussis Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Minhai Biotechnology Recent Developments/Updates
Table 33. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 34. KM Biologics Major Business
Table 35. KM Biologics Pertussis Vaccine Product and Services
Table 36. KM Biologics Pertussis Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. KM Biologics Recent Developments/Updates
Table 38. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 39. Chengdu Institute of Biological Products Major Business
Table 40. Chengdu Institute of Biological Products Pertussis Vaccine Product and Services
Table 41. Chengdu Institute of Biological Products Pertussis Vaccine Sales Quantity (M Doses), Average Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Chengdu Institute of Biological Products Recent Developments/Updates
Table 43. Global Pertussis Vaccine Sales Quantity by Manufacturer (2018-2023) & (M Doses)
Table 44. Global Pertussis Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Pertussis Vaccine Average Price by Manufacturer (2018-2023) & (USD/Doses)
Table 46. Market Position of Manufacturers in Pertussis Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Pertussis Vaccine Production Site of Key Manufacturer
Table 48. Pertussis Vaccine Market: Company Product Type Footprint
Table 49. Pertussis Vaccine Market: Company Product Application Footprint
Table 50. Pertussis Vaccine New Market Entrants and Barriers to Market Entry
Table 51. Pertussis Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Pertussis Vaccine Sales Quantity by Region (2018-2023) & (M Doses)
Table 53. Global Pertussis Vaccine Sales Quantity by Region (2024-2029) & (M Doses)
Table 54. Global Pertussis Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Pertussis Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Pertussis Vaccine Average Price by Region (2018-2023) & (USD/Doses)
Table 57. Global Pertussis Vaccine Average Price by Region (2024-2029) & (USD/Doses)
Table 58. Global Pertussis Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 59. Global Pertussis Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 60. Global Pertussis Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Pertussis Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Pertussis Vaccine Average Price by Type (2018-2023) & (USD/Doses)
Table 63. Global Pertussis Vaccine Average Price by Type (2024-2029) & (USD/Doses)
Table 64. Global Pertussis Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 65. Global Pertussis Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 66. Global Pertussis Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Pertussis Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Pertussis Vaccine Average Price by Application (2018-2023) & (USD/Doses)
Table 69. Global Pertussis Vaccine Average Price by Application (2024-2029) & (USD/Doses)
Table 70. North America Pertussis Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 71. North America Pertussis Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 72. North America Pertussis Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 73. North America Pertussis Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 74. North America Pertussis Vaccine Sales Quantity by Country (2018-2023) & (M Doses)
Table 75. North America Pertussis Vaccine Sales Quantity by Country (2024-2029) & (M Doses)
Table 76. North America Pertussis Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Pertussis Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Pertussis Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 79. Europe Pertussis Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 80. Europe Pertussis Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 81. Europe Pertussis Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 82. Europe Pertussis Vaccine Sales Quantity by Country (2018-2023) & (M Doses)
Table 83. Europe Pertussis Vaccine Sales Quantity by Country (2024-2029) & (M Doses)
Table 84. Europe Pertussis Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Pertussis Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Pertussis Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 87. Asia-Pacific Pertussis Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 88. Asia-Pacific Pertussis Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 89. Asia-Pacific Pertussis Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 90. Asia-Pacific Pertussis Vaccine Sales Quantity by Region (2018-2023) & (M Doses)
Table 91. Asia-Pacific Pertussis Vaccine Sales Quantity by Region (2024-2029) & (M Doses)
Table 92. Asia-Pacific Pertussis Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Pertussis Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Pertussis Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 95. South America Pertussis Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 96. South America Pertussis Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 97. South America Pertussis Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 98. South America Pertussis Vaccine Sales Quantity by Country (2018-2023) & (M Doses)
Table 99. South America Pertussis Vaccine Sales Quantity by Country (2024-2029) & (M Doses)
Table 100. South America Pertussis Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Pertussis Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Pertussis Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 103. Middle East & Africa Pertussis Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 104. Middle East & Africa Pertussis Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 105. Middle East & Africa Pertussis Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 106. Middle East & Africa Pertussis Vaccine Sales Quantity by Region (2018-2023) & (M Doses)
Table 107. Middle East & Africa Pertussis Vaccine Sales Quantity by Region (2024-2029) & (M Doses)
Table 108. Middle East & Africa Pertussis Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Pertussis Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Pertussis Vaccine Raw Material
Table 111. Key Manufacturers of Pertussis Vaccine Raw Materials
Table 112. Pertussis Vaccine Typical Distributors
Table 113. Pertussis Vaccine Typical Customers
List of Figures
Figure 1. Pertussis Vaccine Picture
Figure 2. Global Pertussis Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pertussis Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Whole-cell Vaccines Examples
Figure 5. Acellular Vaccines Examples
Figure 6. Global Pertussis Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Pertussis Vaccine Consumption Value Market Share by Application in 2022
Figure 8. 12 Months Below Examples
Figure 9. 12 Months Above Examples
Figure 10. Global Pertussis Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Pertussis Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Pertussis Vaccine Sales Quantity (2018-2029) & (M Doses)
Figure 13. Global Pertussis Vaccine Average Price (2018-2029) & (USD/Doses)
Figure 14. Global Pertussis Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Pertussis Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Pertussis Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Pertussis Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Pertussis Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Pertussis Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Pertussis Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Pertussis Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Pertussis Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Pertussis Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Pertussis Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Pertussis Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Pertussis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Pertussis Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Pertussis Vaccine Average Price by Type (2018-2029) & (USD/Doses)
Figure 29. Global Pertussis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Pertussis Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Pertussis Vaccine Average Price by Application (2018-2029) & (USD/Doses)
Figure 32. North America Pertussis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Pertussis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Pertussis Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Pertussis Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Pertussis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Pertussis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Pertussis Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Pertussis Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Pertussis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Pertussis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Pertussis Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Pertussis Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Pertussis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Pertussis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Pertussis Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Pertussis Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Pertussis Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Pertussis Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Pertussis Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Pertussis Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Pertussis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Pertussis Vaccine Market Drivers
Figure 73. Pertussis Vaccine Market Restraints
Figure 74. Pertussis Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Pertussis Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Pertussis Vaccine
Figure 78. Pertussis Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
